Home > Insider Trading > Filing (0001181431-14-012051)

Filing Details

Accession Number:: 0001181431-14-012051
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-11 14:34:56
Reporting Period:: 2014-03-07

Filing Date:: 2014-03-11
Accepted Time:: 2014-03-11 14:34:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427925	Acelrx Pharmaceuticals Inc	ACRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190472	A Mark Wan	3200 Alpine Road Portola Valley CA 94028		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-07	46,661	$12.39	3,658,051	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	12,186	$11.96	3,645,865	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-10	298,508	$12.36	3,347,357	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	2,508	$12.39	196,666	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	655	$11.96	196,011	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-10	16,049	$12.36	179,962	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	79,645	$12.39	6,243,889	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	20,800	$11.96	6,223,089	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-10	509,520	$12.36	5,713,569	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	1,759	$12.39	137,862	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-07	459	$11.96	137,403	No	4	S	Indirect	See footnote
Common Stock	Disposition	2014-03-10	11,250	$12.36	126,153	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The shares are owned directly by Three Arch Partners III, L.P. ("TAP III"). Three Arch Management III, L.L.C. ("TAM III"), the general partner of TAP III, has sole voting and dispositive power with respect to the securities held by TAP III. Mark A. Wan and Wilfred Jaeger, the managing members of TAM III, share the voting and dispositive power with respect to the shares held by TAP III. Such persons and entities disclaim beneficial ownership of the shares held by TAP III except to the extent of any pecuniary interest therein.
The shares are owned directly by Three Arch Associates III, L.P. ("TAA III"). TAM III, the general partner of TAA III, has sole voting and dispositive power with respect to the securities held by TAA III. Mark A. Wan and Wilfred Jaeger, the managing members of TAM III, share the voting and dispositive power with respect to the shares held by TAA III. Such persons and entities disclaim beneficial ownership of the shares held by TAA III except to the extent of any pecuniary interest therein.
The shares are owned directly by Three Arch Partners IV, L.P. ("TAP IV"). Three Arch Management IV, L.L.C. ("TAM IV"), the general partner of TAP IV, has sole voting and dispositive power with respect to the securities held by TAP IV. Mark A. Wan and Wilfred Jaeger, the managing members of TAM IV, share the voting and dispositive power with respect to the shares held by TAP IV. Such persons and entities disclaim beneficial ownership of the shares held by TAP IV except to the extent of any pecuniary interest therein.
The shares are owned directly by Three Arch Associates IV, L.P. ("TAA IV"). TAM IV, the general partner of TAA IV, has sole voting and dispositive power with respect to the securities held by TAA IV. Mark A. Wan and Wilfred Jaeger, the managing members of TAM IV, share the voting and dispositive power with respect to the shares held by TAA IV. Such persons and entities disclaim beneficial ownership of the shares held by TAA IV except to the extent of any pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.07 to $13.05, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.90 to $12.01, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.